Listen
HELICOBACTER TEST INFAI
-
Opinions on drugs -
Posted on
Jul 08 2009
- Updated on
Jul 23 2009
Reason for request
Inclusion on the list of medicines refundable by National Health Insurance and approved for hospital use.
-
Clinical Benefit
| Substantial |
The actual benefit of this proprietary medicinal product is substantial. |
Clinical Added Value
| minor |
HELICOBACTER TEST INFAI 45 mg provides a minor improvement in actual benefit (IAB IV) in the diagnostic strategy of ascertaining Helicobacter pylori infection in children aged 3 to 11 in the indications in the marketing authorisation. |
English version
Contact Us
Évaluation des médicaments
